{{Rsnum
|rsid=11059374
|Chromosome=12
|position=127819873
|Orientation=plus
|GMAF=0.1492
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 61.9 | 32.7 | 5.3
| HCB | 67.9 | 27.0 | 5.1
| JPT | 66.4 | 27.4 | 6.2
| YRI | 100.0 | 0.0 | 0.0
| ASW | 84.2 | 15.8 | 0.0
| CHB | 67.9 | 27.0 | 5.1
| CHD | 66.1 | 28.4 | 5.5
| GIH | 77.2 | 21.8 | 1.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 46.6 | 46.6 | 6.9
| MKK | 97.4 | 2.6 | 0.0
| TSI | 69.3 | 29.7 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=2E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}